Summary

Report Scope:

This report covers the worldwide market for SNP genotyping, with the market segmented by technology and application. It provides an in-depth analysis of the SNP genotyping market, including estimates and trends through 2029. In this report, the market is divided into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029. This report also uses analytical frameworks such as PESTEL, examines the competitive landscape, and explores trends in ESG and funding.

Report Includes:

- 37 data tables and 44 additional tables
- An overview of the global market for single nucleotide polymorphism (SNP) genotyping
- Analyses of global market trends, with data from 2021-2023, estimates for 2024, and projected CAGRs through 2029
- Evaluation of the current market size and revenue growth prospects specific to SNP genotyping, along with a market share analysis by technology, application, and region
- Discussion of the advantages of the most frequently used SNP genotyping techniques, such as Sequenom’s MassArray DNA analysis platform, Bruker’s MALDI-TOF array, SNP pyrosequencing, microarrays and gene chips, and Applied Biosystems’ (now part of Thermo Fisher Scientific) SNPlex and TaqMan
- Analysis of the regulatory framework and policies affecting the industry
- Discussion of the ESG practices of, as well as challenges for, companies
- Analysis of the key companies’ market shares and their proprietary technologies, strategic alliances and patents
- Company profiles of the leading players, including Agilent Technologies Inc., F. Hoffman-La Roche Ltd., Illumina Inc., Qiagen, and Thermo Fisher Scientific Inc.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
SNP for Mutational Analysis
SNP Definition
Methods of Studying SNPs
Classification of SNPs
PESTEL Analysis
Political
Economic
Social
Technological
Environmental
Legal
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Declining Prices of DNA Sequencing Methods
Demand for Personalized Treatments
Personalized Medicine and SNP Genotyping in the Drug Development Process
Increasing Demand for Genome Analysis in Plants and Animal Livestock
Market Restraints
Reimbursement Policies
Market Opportunities
Increasing Applications of SNP Genotyping
Rising Investments in Genomics Research
Chapter 4 Emerging Technologies and Developments
SNP-Chip
SNP Genotyping Technologies in Forensic Science
Artificial Intelligence in SNP Genotyping
Chapter 5 Market Segmentation Analysis
Market Trends
Segmentation Breakdown
Global Market for SNP Genotyping, by Technology
Microarrays and GeneChips
SNP Pyrosequencing
TaqMan Allelic Discrimination
Applied Biosystems SNPlex Platform
MassArray Maldi-TOF
Other SNP Genotyping Technologies
Global Market for SNP Genotyping, by Application
Pharmaceuticals and Pharmacogenomics
Diagnostic Research
Agricultural Biotechnology
Animal Genetics
Plant Improvements
Aquaculture
Other Applications
Geographic Breakdown
Global Market for SNP Genotyping, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Funding
Leading Companies
Key Strategies Adopted by Players
Partnerships
Other Strategies
Chapter 7 Sustainability in the SNP Genotyping Market: An ESG Perspective
ESG Performance in the Market
ESG Practices in the SNP Genotyping Industry
Environmental Performance
Social Performance
Governance Performance
ESG Risk Ratings
Concluding Remarks from BCC Research
Chapter 8 Appendix
Methodology
Acronyms
References
Company Profiles
AGILENT TECHNOLOGIES INC.
BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
BIO-RAD LABORATORIES INC.
CYTIVA
ENZO BIOCHEM INC.
EPIGENDX
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
QIAGEN
STANDARD BIOTOOLS
THERMO FISHER SCIENTIFIC INC.